论文部分内容阅读
目的观察臌症丸治疗肝硬化腹水的临床疗效。方法选取医院内近5年肝硬化腹水住院患者61例,按就诊时间先后排序,随机分为两组,奇数序号为治疗组31例(西药常规治疗并口服臌症丸),对照组30例(西药常规治疗),临床观察两组患者的治疗效果。结果治疗组总有效率90.32%,较对照组70.00%高,两组临床疗效比较经秩和检验,差异有统计学意义(P<0.05)。结论臌症丸可有效治疗肝硬化腹水。
Objective To observe the clinical efficacy of Xiongzheng Wan in treating cirrhosis and ascites. Methods Sixty-one inpatients with cirrhosis and ascites in the hospital were enrolled in this study. They were randomly divided into two groups according to the time they were treated. The odd-numbered cases were 31 cases in the treatment group (routine treatment with western medicine and Oral Hypophysis) and 30 cases in the control group Western medicine routine treatment), the clinical observation of the treatment effect of two groups of patients. Results The total effective rate was 90.32% in the treatment group, which was 70.00% higher than that in the control group. The clinical efficacy of the two groups was statistically significant (P <0.05) by rank sum test. Conclusion Hysteria pills can be effective in treating cirrhosis and ascites.